Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review

  • 0Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

|

|

Summary

This summary is machine-generated.

Biomarkers precisely characterize asthma endotypes, guiding biologic therapies. Emerging biomarkers promise more effective asthma management and remission, improving patient outcomes.

Area Of Science

  • Pulmonology and Allergy
  • Translational Medicine

Background

  • Asthma is characterized by chronic airway inflammation and variable airflow obstruction, driven by distinct molecular endotypes.
  • Biomarkers are crucial for endotype characterization, enabling the design, monitoring, and evaluation of asthma biologic therapies in clinical trials.

Purpose Of The Study

  • To review the evolving role of biomarkers in understanding and treating asthma, focusing on approved biologics and novel markers.
  • To highlight how biomarkers have advanced asthma research and clinical practice.

Main Methods

  • Review of established and emerging biomarkers used in asthma research and clinical trials.
  • Focus on biomarkers aiding in the characterization of the eosinophilic type 2 (T2) asthma endotype.
  • Inclusion of biomarkers such as serum IgE, blood eosinophils, FeNO, periostin, sputum cells, TARC, eotaxin-3, EPX, CC16, and QCT imaging.

Main Results

  • Established biomarkers (serum IgE, blood eosinophils, FeNO, periostin) elucidated the T2 asthma endotype.
  • Emerging biomarkers (sputum cells, TARC, eotaxin-3, EPX, CC16, QCT) are increasingly utilized in clinical trials and specialized centers.
  • Biomarkers are integral to evaluating the efficacy of biologic therapies and understanding asthma pathophysiology.

Conclusions

  • Biomarkers are central to the advancement of asthma treatment, particularly biologic therapies.
  • Continued research and application of biomarkers are paving the way for personalized asthma management.
  • The ultimate goal is achieving symptom-free asthma remission without exacerbations through biomarker-guided therapies.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs 01:25

451

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma: Pathogenesis and Management 01:20

576

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-IV: Diagnostic and Management 01:30

2.6K

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
Physical...

Asthma-II: Pathophysiology and Classification 01:26

2.8K

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Initiation of Airway Inflammation:

...

Asthma-IV: Nursing Management 01:30

3.3K

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

Asthma-I: Introduction 01:29

2.8K

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...